WINSTON-SALEM, N.C. (WGHP) — The Wake Forest Institute for Regenerative Medicine says it will help lead a pioneering cancer research project aboard the International Space Station.
The project is one of five chosen through competitive solicitation by the ISS National Lab in partnership with NASA, according to a WFIRM news release.
It aims to explore the effects of a low-gravity environment, or microgravity, on cancer development and treatment.
The project will be led by Dr. Shay Soker and focus on the use of organoids, which are miniature, simplified versions of organs grown in the lab from cells recovered from colorectal cancer patients.
The organoids will be sent to the ISS to study how microgravity affects cancer growth and response to treatment, which could offer insights that could revolutionize cancer therapies here on Earth.
“Being selected for this project is an incredible honor and opportunity for our team at WFIRM,” Dr. …